Drug-Drug Interaction Between PK101-001 and PK101-002

Inclusion Criteria: * Healthy adults ≥ 19 years of age (on the day of screening) * No congenital or chronic diseases and no abnormal signs determined by medical examinations * Not abnormal or not clinical significant lab values * 90mmHg ≤ (SBP) ≤ 139mmHg, 60mmHg ≤ (DBP) ≤ 89mmHg * 18Kg/(m)\^2 ≤ (BMI) ≤30Kg/(m)\^2 Exclusion Criteria: * Subjects who were administered below medications within 30 days (barbiturates, drugs of induced or suppressive drug metabolizing enzyme, etc) * Subjects who were administered medications of prohibition within 10 days * Heavy drinking within 30 days (female: over 14units/week, male:over 21units/week) * Heavy smoker within 30 days (over 20 cigarettes per day) * Subjects who previously participated in other clinical trials or bioequivalence Test within 90 days * Subjects who donated whole blood within 60 days or donated component blood within 14 days or received blood transfusion within 30 days * Subjects who have hypersensitivity for investigational products